Visual Features for Visual Attention
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to understand how the brain decides where to focus attention in busy scenes, such as finding Waldo in a "Where's Waldo" puzzle. Researchers believe certain brain areas, which respond to features like color and motion, help identify important spots in a scene by creating "feature maps" that highlight unique locations. Participants will have their brains scanned with an fMRI while they view images with different feature contrasts to observe how these brain areas function. This trial suits individuals aged 18 to 55 with normal or corrected vision and no history of neurological disease. As an unphased trial, it offers participants the opportunity to contribute to foundational research on brain function and attention.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this method is safe for participants?
Research shows that using fMRI to study visual attention is safe. Functional MRI (fMRI) is a common tool that reveals which brain areas activate during specific tasks. It doesn't use radiation or require injections, making it a low-risk method.
In similar studies, participants viewed images with varying colors, movements, or brightness to observe brain reactions. No serious side effects have been reported from this type of research. Participants might feel uncomfortable lying still in the MRI machine, and some may experience slight claustrophobia, but these are usually the only issues.
Overall, participants tolerate this method well. For those considering joining a trial using fMRI, it is reassuring to know that it is a safe way to explore brain function.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores how different levels of visual salience affect our ability to focus on specific visual details. Unlike typical visual attention studies that might not vary the intensity of visual features, this trial manipulates feature contrast in terms of color, motion direction, and luminance to understand how these changes can enhance or hinder visual cognition. By probing these dimensions, the study aims to uncover new insights into how our brains prioritize visual information, potentially leading to innovative strategies for improving attention-related conditions.
What evidence suggests that this method is effective for understanding visual attention?
Research shows that the brain uses "feature dimension maps" to focus on important visual details, such as color or motion, guiding attention. Studies suggest these maps help the brain identify important elements in a scene by highlighting standout areas. When an object differs from its background, these maps direct the brain to focus on it. Computational models have demonstrated that these maps significantly influence automatic attention. This trial will explore how these brain processes work by manipulating graded feature salience, but past research has already shown their crucial role in directing visual attention.12367
Who Is on the Research Team?
Tommy C Sprague
Principal Investigator
University of California, Santa Barbara
Are You a Good Fit for This Trial?
This trial is for healthy individuals interested in how the brain processes visual information. Participants should be able to focus on a task without moving their eyes, as they will view stimuli with varying levels of 'salience' or importance, like color and motion differences.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Anatomical & Retinotopic Mapping
Participants undergo an anatomical and retinotopic mapping session to identify brain regions for further analysis
Experimental fMRI Sessions
Participants engage in visual attention tasks during fMRI scanning to study the role of feature-selective brain regions
Follow-up
Participants are monitored for safety and effectiveness after the experimental sessions
What Are the Treatments Tested in This Trial?
Interventions
- Probing the Role of Feature Dimension Maps in Visual Cognition: Impact of Salience Level (Expt 1.1)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Santa Barbara
Lead Sponsor
National Eye Institute (NEI)
Collaborator